Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.
Latest
16:30 ET Thermo Fisher Scientific Declares Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly...
16:11 ET The Mass Spectrometry Market Forecast 2017-2027
Report Details Mass spectrometry – our new study reveals trends, R&D progress, and predicted revenues Where is the mass spectrometry market...
16:10 ET ESSA Pharma Announces Overnight Marketed Equity Offering
HOUSTON and VANCOUVER, July 12, 2017 /PRNewswire/ - ESSA Pharma Inc. (TSX: EPI; NASDAQ: EPIX) ("ESSA" or the "Company"), a clinical-stage...
16:03 ET Biocom Applauds Passage of FDA Reauthorization Act
Biocom, the association representing the California life science industry, issued the following statement regarding passage of H.R.2430, the FDA...
15:38 ET Mexico Radiosurgery Market Outlook to 2023
Summary GlobalData's new report, "Mexico Radiosurgery Market Outlook to 2023", provides key market data on the Mexico Radiosurgery market. The...
15:31 ET Brazil Neurosurgical Products Market Outlook to 2023
Summary GlobalData's new report, "Brazil Neurosurgical Products Market Outlook to 2023", provides key market data on the Brazil Neurosurgical...
15:28 ET Biosurgery: Technologies and Global Markets
Report Highlights The global biosurgery market should reach $12.5 billion by 2021 from $8.3 billion in 2016 at a compound annual growth rate...
15:17 ET Stem Cells Market Analysis By Product (Adult Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By Technology, By Therapy, And Segment Forecasts, 2014 - 2025
The global stem cell market is expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View...
14:10 ET Avant Diagnostics Acquires Exclusive Option to License Genetic Health Solution Technology Platform
- Genetic Health Solution platform helps chronic disease patient management - Patient-centric biomarker-based wellness programs...
13:25 ET Actinobac Biomed, Inc., Receives Investment To Advance Promising Treatment for Blood Cancers
Actinobac Biomed Inc., started with an investment from Foundation Venture Capital Group (FVCG), Inc., an affiliate of New Jersey Health Foundation...
13:14 ET La cénégermine, collyre en solution est approuvé en Europe : le premier médicament biotechnologique issu des recherches de Dompé dans le traitement de la kératite neurotrophique modérée à sévère chez l'adulte est produit en Italie
- Le développement de la cénégermine est le fruit de dizaines d'années de recherches italiennes issues des études de Rita Levi...
12:00 ET Dr. Natalia Inada is Recipient of 2017 Award for PDT Clinical Trial Excellence
At the 16th International Photodynamic Association (IPA) World Congress in Coimbra, Dr. Natalia Inada was the recipient of the 2017 AWARD FOR PDT...
12:00 ET Dr. Pilar Acedo Nunez is Recipient of 2017 IPA Early Investigator Award
At the 16th International Photodynamic Association (IPA) World Congress in Coimbra, Dr. Pilar Acedo Nunez was the recipient of the 2017 IPA EARLY...
12:00 ET Mr. Colin Hopper Receives IPA Lifetime Achievement Award in PDT Clinical Research
At the 16th International Photodynamic Association (IPA) World Congress in Coimbra, Mr. Colin Hopper was the recipient of the 2017 LIFETIME...
11:00 ET ExL Events Hosts 5th Promotional Review Committee Compliance & Best Practices October 16-17, Florham Park, NJ
ExL Events is hosting the 5th Annual Promotional Review Committee Compliance & Best Practices conference on October 16–17, 2017 at the Wyndham...
09:52 ET Portage Announces Results of Shareholders Meeting and Provides Update on its Portfolio Companies
TORONTO, July 12, 2017 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), provides...
09:42 ET Korea Approves the World's First Cell and Gene Therapy for Knee Osteoarthritis
TissueGene, Inc. ("TissueGene"), a Maryland-based regenerative medicine company, announced today that Kolon Life Science, TissueGene's exclusive...
09:00 ET Evivo™ Protects Babies From the Inside Out
Evolve BioSystems, Inc. announces the introduction of Evivo (www.evivo.com/press), the first and only probiotic clinically proven to restore a...
09:00 ET Pinnacle Spine Group Issued Newest Patent for In Situ Graft Delivery to a Fusion Device
Pinnacle Spine Group, LLC, the pioneer of in-situ graft delivery technology, today announced that the company has been granted a U.S. patent that...
08:50 ET Oramed to Present at BIT'S 5th World Congress of Diabetes on July 13, 2017
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...
08:45 ET Biotech Stocks Ride Momentum in Anticipation of Favorable Governmental Policy Environment
Biotech and Pharma Companies with innovative technologies and development pipelines are gaining strong interest among investors as treatments and...
08:45 ET Cannabics Pharmaceuticals Executed a Final Collaboration Agreement with SIMFO GmbH
Cannabics Pharmaceuticals Inc. (CNBX) today announced it has executed a Collaboration Agreement with SIMFO GmbH, a world leader in cancer...
08:32 ET US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology
AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa) announced that it has received grant status for the patent application: SYNTHETIC...
08:30 ET QR Pharma, Inc. Presents New Data on Posiphen in Down Syndrome at the Alzheimer's Disease International Conference (AAIC 2017 London)
QR Pharma, Inc., a privately held phase 2 biopharmaceutical company developing novel therapies for the treatment of Alzheimer's (AD), Parkinson's...
08:30 ET Bio-Techne To Host Conference Call On August 8, 2017 To Announce Fourth Quarter Financial Results
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on August 8, 2017, at 8:00 a.m. CDT to review...